APA (7th ed.) Citation

Jasenosky, L. D., Cadena, C., Mire, C. E., Borisevich, V., Haridas, V., Ranjbar, S., . . . Goldfeld, A. E. (2019). The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus. iScience, 19, 1279-1290. https://doi.org/10.1016/j.isci.2019.07.003

Chicago Style (17th ed.) Citation

Jasenosky, Luke D., et al. "The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus." IScience 19 (2019): 1279-1290. https://doi.org/10.1016/j.isci.2019.07.003.

MLA (9th ed.) Citation

Jasenosky, Luke D., et al. "The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus." IScience, vol. 19, 2019, pp. 1279-1290, https://doi.org/10.1016/j.isci.2019.07.003.